Introduction
Onychomycosis, accounting for approximately 50% of the nail diseases, is a common chronic fungal infection of the nail plate or nail bed caused by dermatophytes, yeasts, and nondermatophyte molds (NDMs) [1] . With healthy nail appearance becoming more and more important for social reasons, increasing attention is paid to the treatment of onychomycosis [2] .
While the incidence of onychomycosis keeps growing up and the worldwide prevalence shows 5.5%, dermatophytes, particularly Trichophyton rubrum, are still responsible for the most of fungal nail infection [2] . Among patients with onychomycosis in Dakar, to our surprise, yeasts can be as high as 68.4%-75% of the isolates [3, 4] . In spite of C.albicans, non-C.albicans candida species such as C.tropicalis, C.parapsilosis and others were also reported sharing 40% of the fingernail onychomycosis.
C.guilliermondii is a normal component of human microbes on skin and mucous membranes, conditionally causing infection, especially among immunodeficient people [5] . C.guilliermondii onycomycosis is reported for the first time; in addition, the patient is an immunocompetent person.
Case
A 50-year-old healthy male farmer showed up in our clinic on day −7, several fingernails of whose left hand turned yellow and thickened in one year without any symptom. He denied any hand trauma or glucocorticoid using. In general, his left thumb, middle finger and little finger appeared as the type of distal and lateral subungual onychomycosis (DLSO) with crumbed nail plate, yellowish, brownish, partially thickened and friable; while the forefinger showed proximal subungual onychomycosis (PSO) with slight indentations (Fig. 1a) .
Scales of the nail lesion were collected and then observed directly under the microscopy, presenting plenty of spores (Fig. 2) . The result of culture turned out with yeast-like colonies as white and smooth as cheese, illustrating the characteristic morphophysiological features of candida species (Fig. 3) . rRNA gene sequence analysis after PCR using the universal primer internal transcribed spacer (ITS1/ITS4) confirmed that it had 99.67% homology with that of Pichia guilliermondii (Meyerozyma guilliermondii) (GenBank Accession No. MN473285.1).
Considering all of the clinical characters and experimental results, the patient was diagnosed as C.guilliermondii onychomycosis. Antifungal therapy was started on day 0 with oral itraconazole in doses of 200mg twice daily and finished on day +7 as the first treatment course. The same dosage of the second course and the third course, respectively, from day +28 to day +35 and day +56 to day +63. At his first followup on day +28, the nail lesions improved significantly (Fig. 1b) . The patient reported cured in a telephone follow-up on day +6 months, but regretfully, haven't provided with any picture.
This case promoted us to analyze the epidemiology of onychomy- Table 1 ). All the data we have collected and analyzed is presented in the supplement with references. Comparisons among the proportions of species have been made within different periods and different provinces (see detail in supplement). The comparison came out with more yeast while less dermatophyte cases happening than before ( Fig. 4) , especially in Jiangsu Province and Guangdong Province (Fig. 5 ).
Discussion
Although majority of the former studies declared dermatophytes to be the predominant pathogens, different sounds appear in etiology recently. We did a partial analysis of the epidemiology in Iran [6] , grouping them into two periods with one from 2000 to 2007 and the other from 2007 to 2015, finding that dermatophytes decreased significantly during years while NDMs increased instead (Fig. 6 ). Meanwhile, a novel systematic review and meta-analysis in Iran has demonstrated that yeasts are the predominant etiologic agents in 17 studies (70.8%) while dermatophytes in 5 studies (20.9%) [6] , similar to the findings in Colombia [7] and Italy [8] . The epidemiology of onychomycosis in China has also shown changes for many years (see the supplements), as the number of yeast cases increased in recent years. Since the epidemiology of onychomycosis has changed and the yeast proportion has increased, more attention should be paid on yeast onychomycosis, especially the most important candida ones.
Pichia guilliermondii is the sexual reproduction period of C. guilliermondii, with another name of Meyerozyma guilliermondii, inducing infections as opportunistic pathogens particularly in immunocompromised patients. Pichia guilliermondii has been rarely reported, one pulmonary nodules [9] and few candidemia [10] , and the patients infected are often accompanied by type 2 diabetes and those who receiving total parenteral nutrition. Our report might be the first time to present such a particular onychomycosis case of C. guilliermondii.
In literatures, the recommending oral medications for onychomycosis includes terbinafine, itraconazole and fluconazole. The guidelines of onychomycosis in China [11] and Britain [12] share similar tips that terbinafine and itraconazole are the first-line medication compared to fluconazole. Terbinafine is found to have more effects on dermatophytes onychomycosis with the clearance up to 70%, while itraconazole shows more effective in yeasts infection. According to the guidelines and our clinical experience, itraconazole shows more significant efficiency than terbinafine in the treatment of candida infections. As a result, we chose oral itraconazole therapy for this patient which finally worked. Unfortunately, drug sensitive test hadn't been adopted to achieve the most appropriate drug and make a further verification here.
Different from the former cases, we found our patient healthy without personal or family history of diabetes or immunosuppressive therapy, indicating the significance in the further study of species epidemiology and the development of a rapid, accurate and convenient diagnosis of fungal infections in clinic. The low-morbidity species of candida onychomycosis leaves unspecific antifungal therapy, though, empirical therapy before the result of drug sensitive test comes out is of great importance.
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